vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and Microvast Holdings, Inc. (MVST). Click either name above to swap in a different company.

Microvast Holdings, Inc. is the larger business by last-quarter revenue ($96.4M vs $93.1M, roughly 1.0× HIVE Digital Technologies Ltd.). Microvast Holdings, Inc. runs the higher net margin — 17.2% vs -98.1%, a 115.2% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -15.0%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 8.9%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Microvast Holdings, Inc. is a battery technology company headquartered in Stafford, Texas, and publicly traded on the NASDAQ Stock Exchange. It designs, develops and manufactures battery components and systems primarily for electric commercial vehicles and utility-scale energy storage systems (ESS). Microvast has manufacturing facilities in the United States, China, and Germany.

HIVE vs MVST — Head-to-Head

Bigger by revenue
MVST
MVST
1.0× larger
MVST
$96.4M
$93.1M
HIVE
Growing faster (revenue YoY)
HIVE
HIVE
+233.5% gap
HIVE
218.6%
-15.0%
MVST
Higher net margin
MVST
MVST
115.2% more per $
MVST
17.2%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
8.9%
MVST

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
MVST
MVST
Revenue
$93.1M
$96.4M
Net Profit
$-91.3M
$16.5M
Gross Margin
-27.1%
1.0%
Operating Margin
-42.7%
Net Margin
-98.1%
17.2%
Revenue YoY
218.6%
-15.0%
Net Profit YoY
-234.0%
120.1%
EPS (diluted)
$-0.38
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
MVST
MVST
Q4 25
$93.1M
$96.4M
Q3 25
$87.3M
$123.3M
Q2 25
$45.6M
$91.3M
Q1 25
$116.5M
Q4 24
$29.2M
$113.4M
Q3 24
$22.6M
$101.4M
Q2 24
$32.2M
$83.7M
Q1 24
$81.4M
Net Profit
HIVE
HIVE
MVST
MVST
Q4 25
$-91.3M
$16.5M
Q3 25
$-15.8M
$-1.5M
Q2 25
$35.0M
$-106.1M
Q1 25
$61.8M
Q4 24
$68.2M
$-82.3M
Q3 24
$80.0K
$13.2M
Q2 24
$-18.3M
$-101.6M
Q1 24
$-24.8M
Gross Margin
HIVE
HIVE
MVST
MVST
Q4 25
-27.1%
1.0%
Q3 25
4.7%
37.6%
Q2 25
-13.6%
34.7%
Q1 25
36.9%
Q4 24
-43.7%
36.6%
Q3 24
-66.1%
33.2%
Q2 24
-7.4%
32.5%
Q1 24
21.2%
Operating Margin
HIVE
HIVE
MVST
MVST
Q4 25
-42.7%
Q3 25
10.5%
Q2 25
17.8%
Q1 25
16.3%
Q4 24
-1.2%
Q3 24
7.1%
Q2 24
-118.0%
Q1 24
-28.4%
Net Margin
HIVE
HIVE
MVST
MVST
Q4 25
-98.1%
17.2%
Q3 25
-18.1%
-1.2%
Q2 25
76.8%
-116.1%
Q1 25
53.0%
Q4 24
233.2%
-72.6%
Q3 24
0.4%
13.1%
Q2 24
-56.7%
-121.4%
Q1 24
-30.5%
EPS (diluted)
HIVE
HIVE
MVST
MVST
Q4 25
$-0.38
$0.19
Q3 25
$-0.07
$0.00
Q2 25
$0.18
$-0.33
Q1 25
$0.05
Q4 24
$0.52
$-0.24
Q3 24
$0.00
$0.03
Q2 24
$-0.17
$-0.32
Q1 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
MVST
MVST
Cash + ST InvestmentsLiquidity on hand
$105.0M
Total DebtLower is stronger
$13.2M
Stockholders' EquityBook value
$559.3M
$410.5M
Total Assets
$624.0M
$1.0B
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
MVST
MVST
Q4 25
$105.0M
Q3 25
$90.7M
Q2 25
$99.7M
Q1 25
$90.9M
Q4 24
$40.5M
$73.0M
Q3 24
$31.7M
$63.6M
Q2 24
$68.2M
Q1 24
$39.5M
Total Debt
HIVE
HIVE
MVST
MVST
Q4 25
$13.2M
Q3 25
$34.4M
Q2 25
$34.2M
Q1 25
$41.3M
Q4 24
$41.1M
Q3 24
$53.4M
Q2 24
$34.2M
Q1 24
$43.0M
Stockholders' Equity
HIVE
HIVE
MVST
MVST
Q4 25
$559.3M
$410.5M
Q3 25
$624.6M
$358.1M
Q2 25
$560.5M
$356.1M
Q1 25
$454.2M
Q4 24
$430.9M
$387.9M
Q3 24
$275.5M
$486.1M
Q2 24
$268.6M
$455.0M
Q1 24
$546.1M
Total Assets
HIVE
HIVE
MVST
MVST
Q4 25
$624.0M
$1.0B
Q3 25
$693.0M
$1.0B
Q2 25
$628.7M
$1.0B
Q1 25
$982.9M
Q4 24
$478.6M
$951.9M
Q3 24
$334.7M
$997.9M
Q2 24
$961.4M
Q1 24
$1.0B
Debt / Equity
HIVE
HIVE
MVST
MVST
Q4 25
0.03×
Q3 25
0.10×
Q2 25
0.10×
Q1 25
0.09×
Q4 24
0.11×
Q3 24
0.11×
Q2 24
0.08×
Q1 24
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
MVST
MVST
Operating Cash FlowLast quarter
$46.0M
$16.4M
Free Cash FlowOCF − Capex
$15.8M
FCF MarginFCF / Revenue
16.4%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters
$56.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
MVST
MVST
Q4 25
$46.0M
$16.4M
Q3 25
$-10.6M
$15.2M
Q2 25
$10.2M
$37.2M
Q1 25
$7.2M
Q4 24
$-28.5M
$6.1M
Q3 24
$-2.2M
$-5.4M
Q2 24
$-4.4M
$111.0K
Q1 24
$2.0M
Free Cash Flow
HIVE
HIVE
MVST
MVST
Q4 25
$15.8M
Q3 25
$1.2M
Q2 25
$34.3M
Q1 25
$4.8M
Q4 24
$-55.5M
$5.7M
Q3 24
$-34.7M
$-19.6M
Q2 24
$-2.8M
Q1 24
$-8.2M
FCF Margin
HIVE
HIVE
MVST
MVST
Q4 25
16.4%
Q3 25
1.0%
Q2 25
37.5%
Q1 25
4.1%
Q4 24
-189.9%
5.1%
Q3 24
-153.4%
-19.3%
Q2 24
-3.4%
Q1 24
-10.1%
Capex Intensity
HIVE
HIVE
MVST
MVST
Q4 25
0.7%
Q3 25
11.3%
Q2 25
3.1%
Q1 25
2.0%
Q4 24
92.5%
0.3%
Q3 24
143.9%
14.0%
Q2 24
3.5%
Q1 24
12.6%
Cash Conversion
HIVE
HIVE
MVST
MVST
Q4 25
0.99×
Q3 25
Q2 25
0.29×
Q1 25
0.12×
Q4 24
-0.42×
Q3 24
-26.94×
-0.41×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

MVST
MVST

Europe$35.1M36%
CN$32.5M34%
US$21.5M22%
Other$7.2M8%

Related Comparisons